Gold Hard Steel Plus Liquid recalled for undeclared acetaminophen and sildenafil
FDA has recalled Gold Hard Steel Plus Liquid because the product was marketed without FDA approval and contains undeclared pharmaceutical ingredients: acetaminophen and sildenafil.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA classified this as a Class I recall, the most serious category for drug recalls. The product was marketed without an approved NDA/ANDA and contained undeclared acetaminophen and sildenafil.
Plain-English summary
Gold Hard Steel Plus Liquid, sold in 2 FL OZ bottles (UPC 787188873199), is being recalled by Supercore Products Group Inc. The FDA classified this as a Class I recall, the most serious classification for drug recalls.
The product was marketed and sold without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). FDA analysis determined the product contained undeclared acetaminophen and sildenafil.
The recall affects approximately 615 units that were distributed nationwide in the United States, as well as Canada, the United Kingdom, Israel, Australia, Pakistan, Morocco, and the Republic of Kosovo. All lot codes are included in this recall.
Consumers who have purchased this product should stop using it immediately. Those who have already used this product should consult with a healthcare provider.
The recalled product
- Product
- Gold Hard Steel Plus Liquid, 2 FL OZ bottles, UPC 787188873199
- Manufacturer
- Supercore Products Group Inc.
- Hazard
- undeclared-acetaminophen
- undeclared-sildenafil
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27